This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Immunodiagnostic Systems Holdings PLC
Immunodiagnostic Systems Holdings PLC, commonly referred to as IDS, is a leading player in the immunodiagnostics industry, headquartered in the United Kingdom. Founded in 1977, IDS has established itself as a pioneer in the development and manufacture of innovative diagnostic solutions, primarily focusing on immunoassay technology for clinical laboratories. With a strong presence in Europe, North America, and Asia, IDS offers a diverse range of products, including automated immunoassay analysers and a comprehensive portfolio of assays. Their unique approach combines advanced technology with a commitment to quality, ensuring reliable and accurate results for healthcare professionals. Recognised for its significant contributions to the field, IDS has achieved notable milestones, including the expansion of its product line and strategic partnerships that enhance its market position. As a trusted name in immunodiagnostics, IDS continues to drive advancements in healthcare diagnostics.
DitchCarbon Score
How does Immunodiagnostic Systems Holdings PLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Immunodiagnostic Systems Holdings PLC's score of 46 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Immunodiagnostic Systems Holdings PLC, headquartered in Great Britain, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Revvity, Inc., and any climate commitments or emissions data would be cascaded from this parent organization. As of now, Immunodiagnostic Systems Holdings PLC has not established specific reduction targets or initiatives, nor does it appear to have made any formal climate pledges. The lack of documented emissions data and reduction initiatives suggests that the company may be in the early stages of developing its climate strategy. For context, the parent company, Revvity, Inc., may have its own sustainability goals and emissions data that could influence the subsidiary's future commitments. However, without specific information from Revvity, Inc. regarding their emissions or climate initiatives, it is challenging to provide a detailed overview of Immunodiagnostic Systems Holdings PLC's carbon footprint or climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 2,289,000 | 0,000,000 |
| Scope 2 | 29,844,000 | 00,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Immunodiagnostic Systems Holdings PLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
